Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viatris Inc (NQ: VTRS ) 11.45 -0.17 (-1.46%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Viatris Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > These 10 Stocks Were S&P 500's Worst Performers In Biden's First Year: Could Trend Continue If Harris Wins 2024 Election? November 02, 2024 The S&P 500 enjoyed a strong year in 2021, the first year with Joe Biden in the White House. Not all stocks were up and past results could show sectors to avoid ahead of the 2024 election. Via Benzinga Topics Stocks Exposures US Equities FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes November 01, 2024 Lexicon Pharmaceuticals' sotagliflozin, under review as an adjunct to insulin for type 1 diabetes and CKD, faced an FDA panel vote against approval, with mixed expert support. Via Benzinga Exposures Product Safety How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit October 01, 2024 How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit Via News Direct Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday? September 24, 2024 Regeneron filed an appeal after a court's decision, which was issued under seal. Via Benzinga Peering Into Viatris's Recent Short Interest May 27, 2024 Via Benzinga Looking Into Viatris's Recent Short Interest March 15, 2024 Via Benzinga EXCLUSIVE: Options Expert Warns Of 'Terrible Week' After Friday's Triple Witching September 20, 2024 CC Lagator of Options AI warns traders to expect increased volatility in the week after September's 'triple witching,' with over $5 trillion in options expiring and historical evidence of market... Via Benzinga Topics Artificial Intelligence Stocks Exposures Artificial Intelligence US Equities JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability September 06, 2024 JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris. Via Benzinga Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production September 06, 2024 Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally. Via Benzinga 3 Top Value Stocks to Buy Right Now August 20, 2024 Value stocks offer potential for significant returns in today's overheated market. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session August 15, 2024 Via Benzinga US Drugmaker Viatris Q2 Earnings Edge Out Analysts Expectation On Strong Demand For Branded And Generic Drugs August 08, 2024 Viatris reports Q2 revenue of $3.78 billion, with strong growth in Greater China and new product launches driving results. Adjusted EPS of $0.69 beats estimates, and the company raises its 2024 sales... Via Benzinga Why Viatris Stock Is Jumping Today August 08, 2024 Investors are applauding the healthcare company's improving growth story. Via The Motley Fool Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs August 06, 2024 Henrietta Lacks' family sues Novartis and Viatris for profiting from her HeLa cells without consent. The lawsuit seeks profits and aims to prevent further unauthorized use of the cells. Via Benzinga Topics Lawsuit Exposures Financial Legal 3 Surprisingly Underrated Stocks to Buy Right Now July 26, 2024 These stocks arguably deserve more respect from investors. Via The Motley Fool Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio? July 21, 2024 Top performers last week: $WBD up 18.28%, $MSTR up 16.74%, $DHI up 12.91%, $COIN up 12.39%, $OQL up 7.89%, $UNH up 7.84%, $STT up 7.21%, $LEN up 7.07%, $TOST up 7.05%, $EPAM up 6.97%. Are they in your... Via Benzinga S&P 500 Four Under Five June 28, 2024 The S&P 500's strong first half, with gains exceeding 15%, has pushed its valuation even higher. Via Talk Markets Topics Stocks Exposures US Equities Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast May 09, 2024 Viatris reports Q1 EPS in line with consensus at $0.67, with sales slightly missing expectations at $3.66 billion. Strong growth in Emerging Markets and Europe offset by challenges in North America.... Via Benzinga Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday? May 09, 2024 Wall Street is seeing a day of gains as all major indices traded in the green around noon in New York, driven by a surprising uptick in unemployment claims prompting speculation over Federal Reserve... Via Benzinga Topics Economy Exposures Interest Rates VTRS Stock Earnings: Viatris Meets EPS, Misses Revenue for Q1 2024 May 09, 2024 VTRS stock results show that Viatris met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace BTIG Research Predicts Over 118% Rally for These 3 Stocks April 15, 2024 Wall Street stock predictions can run wild but after the tech sector's gains, these stocks could be better places for your money. Via InvestorPlace Steady Returns Ahead: 3 Dividend Stocks for Stable Income in Q2 April 03, 2024 Discover three top dividend stocks for stable income in April that combine sustainable returns and long-term growth. Via InvestorPlace Is Viatris a Great Dividend Stock or Just a Value Trap? March 14, 2024 Investors can collect a high yield with Viatris, but is it a risky payout to rely on? Via The Motley Fool 2 Dirt Cheap Dividend Stocks to Buy and Hold March 11, 2024 These companies aren't popular on the market right now, but income investors will like them. Via The Motley Fool Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris March 11, 2024 From Scott+Scott Attorneys at Law and Hedin Hall LLP Via Business Wire Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday? February 28, 2024 Stocks dipped modestly following a report indicating a marginal downward revision in the U.S. economic growth rate for the last quarter of the year. Via Benzinga Topics Economy Exposures Interest Rates Viatris And Idorsia Forge Global Partnership For Breakthrough Heart Attack Treatments February 28, 2024 Viatris and Idorsia collaborate on groundbreaking heart attack treatments, leveraging innovative therapies for acute conditions. Via Benzinga Earnings Scheduled For February 28, 2024 February 28, 2024 Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. Via Benzinga 3 Overextended Stocks That Need to Slash Their Dividends ASAP February 27, 2024 The most common attribute of overextended stocks other than carrying too much debt is dividends that are too big. Via InvestorPlace 3 Bargain Stocks to Snatch Up Before They Bounce Back February 26, 2024 The market is a weighing machine in the long run, meaning these bargain stocks will deliver impressive forward returns. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
